Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

Clinical trial NCT02042001 · COMPLETED

Trial details

NCT number: NCT02042001
Sponsor: Azienda Ospedaliera San Gerardo di Monza
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Impaired Cognition Depression/Anxiety Poor Quality Sleep Quality of Life HIV-1 Infection

Start date: 2015-07-01
Primary completion: 2017-07-03
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.